Screener
Veradermics MANE Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Veradermics in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The source filing: Veradermics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 5:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001827635-26-000019
| (in thousands, except share and per share amounts) | As of March 31, 2026 | As of December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $168,412 | $21,766 |
| Marketable securities at fair value | 222,385 | 120,096 |
| Prepaid expenses and other current assets | 6,272 | 10,632 |
| Total current assets | 397,069 | 152,494 |
| Long-term assets: | ||
| Property, plant and equipment, net | 21 | 22 |
Item 1. Condensed Consolidated Financial Statements (
FAQ
- What is Veradermics's short-term investments?
- Veradermics (MANE) reported short-term investments of $222.39M in Q1 2026.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Veradermics's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude